Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy. [electronic resource]
Producer: 20190211Description: 156-163 p. digitalISSN:- 1532-8708
- Adrenal Cortex Hormones -- adverse effects
- Aged
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized -- adverse effects
- Arthritis -- chemically induced
- B7-H1 Antigen -- antagonists & inhibitors
- Female
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Nivolumab -- adverse effects
- Pneumonia -- chemically induced
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Progression-Free Survival
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.